New combo therapy aims to tame tough pancreatic tumors
Disease control
Recruiting now
This early-stage study tests a drug called XER-001 given through a tube into the small intestine, combined with precise radiation, for people with locally advanced pancreatic cancer. The goal is to find the safest dose and see if the treatment can control the tumor. About 36 adul…
Phase: PHASE1, PHASE2 • Sponsor: Xerient Pharma • Aim: Disease control
Last updated May 11, 2026 20:39 UTC